检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.
研究兴趣

论文共 679 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Association Between Severe Cardiovascular Events and Time Following Exacerbations of COPD: Meta-analyses of EXACOS-CV Observational Studies From 8 Countries
M. Pollack, C. Nordon, K. Rhodes, M. Lobier, J. Marshall, H. Mullerova, A. Salosensaari, A. Cristina Santos,C. Vogelmeier, S. O Simons
A48. COPD EXACERBATIONS AND HOSPITALIZATIONS: DETERMINANTS AND DRIVERS (2024)
引用0浏览0引用
0
0
Efficacy and Safety of Dupilumab for COPD with Type 2 Inflammation Indicated by Elevated Eosinophils
S Bhatt, H Watz, K Rabe, N Hanania,C Vogelmeier, J Cole, M Bafadhel, S Christenson, A Papi, D Singh, E Laws, X Lu,
64. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. Pneumologie (2024)
引用0浏览0引用
0
0
Efficacy and Safety of Dupilumab in Patients With Moderate-to-Severe COPD and Type 2 Inflammation: Phase 3 NOTUS Trial
S.P. Bhatt, K.F. Rabe, N.A. Hanania,C.F. Vogelmeier, M. Bafadhel, S.A. Christenson, A. Papi, D. Singh, E. Laws, B. Akinlade, J. Maloney, X. Lu,
B14. LATE BREAKING ABSTRACTS: SCIENCE THAT WILL IMPACT CLINICAL CARE (2024)
引用0浏览0引用
0
0
Reduced Risk of Mortality for COPD Patients Associated with Initiation of Treatment with Single Inhaler Triple Therapy (Budesonide/Glycopyrrolate/Formoterol) Versus Multiple Inhaler Triple Therapy in the United States: The MAZI Study
M. Pollack, E. Rapsomaniki, A. Anzueto, K. Rhodes, N. Hawkins,C. Vogelmeier, J. Marshall, H. Mullerova
B52. EVIDENCE FOR THERAPEUTIC STRATEGIES IN COPD: FROM ESTABLISHED TO EMERGING (2024)
引用0浏览0引用
0
0
Prädiktoren einer akuten COPD Exazerbation (PACE-Studie) – erste Ergebnisse zum EXACT Tagebuch
D Leitl, R Glöckl, T Schneeberger, I Jarosch, W Hitzl, M Wittenberg,C Vogelmeier, A Koczulla, K Kenn
64. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. Pneumologie (2024)
引用0浏览0引用
0
0
Dupilumab Improves Post-bronchodilator Lung Function in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation: Data From the Phase 3 Boreas Trial
N.A. Hanania, S.P. Bhatt, K.F. Rabe,C.F. Vogelmeier, M. Bafadhel, S.A. Christenson, A. Papi, D. Singh, E. Laws, C. Nivens, A. Bansal, X. Lu,
A27. EMERGING TREATMENTS AND THERAPEUTIC STRATEGIES IN COPD: RESULTS OF CLINICAL TRIALS AND OBSERVATIONAL STUDIES (2024)
引用0浏览0引用
0
0
GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
Alvar Agusti,Michael Böhm,Bartolomé Celli,Gerard J. Criner,Ana Garcia-Alvarez,Fernando Martinez,Don D. Sin,Claus F. Vogelmeier
Clinical research in cardiology : official journal of the German Cardiac Societyno. 2 (2024): 195-204
引用0浏览0WOS引用
0
0
Blood eosinophil count predicts disease severity in hospitalised community-acquired pneumonia
B Weckler, H Pott, A Race, N Jugkaeo, K Karki, S Ringshandl, C Seidemann, I Schöndorf, H Renz, S Fähndrich, A Jung, W Bertrams,
64. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. Pneumologie (2024)
引用0浏览0引用
0
0
Potential systemic effects of acquired CFTR dysfunction in COPD
Marc Miravitlles,Gerard J. Criner, Marcus A. Mall, Steven M. Rowe,Claus F. Vogelmeier, Bettina Hederer, Matthias Schoenberger,Pablo Altman
RESPIRATORY MEDICINE (2024): 107499-107499
引用0浏览0WOS引用
0
0
Efficacité et sécurité du dupilumab chez des patients atteints de BPCO avec une inflammation de type 2 (élévation des éosinophiles)
S. Bhatt, G. Devouassoux, K. Rabe, N. Hanania,C. Vogelmeier, J. Cole, M. Bafadhel, S. Christenson, A. Papi,D. Singh, E. Laws, X. Lu,
Revue des Maladies Respiratoires Actualitésno. 1 (2024): 95-96
引用0浏览0引用
0
0
加载更多
作者统计
  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn